• Embed Doc
  • Copy Link
  • Readcast
  • Collections
  • CommentGo Back
Download
 
EXECUTIVE SUMMARY
This report has been made keeping in mind the Indian Pharmaceuticalindustry, its growth rate as compared to the global PharmaceuticalIndustry. India's US$ 3.1 billion pharmaceutical industry is growing atthe rate of 14 percent per year. It is one of the largest and mostadvanced among the developing countries.The Indian Pharmaceutical sector is highly fragmented with more than20,000 registered units. It has expanded drastically in the last twodecades. The leading 250 pharmaceutical companies control 70% of the market with market leader holding nearly 7% of the market share.It is an extremely fragmented market with severe price competitionand government price control.Then, we look at the market and growth scenario of Pharmaceuticalcompanies in India which brings us to research on MATRIX PHARMALABS.
 
PHARMACEUTICAL INDUSTRY PROFILE
The
pharmaceutical industry
develops, produces, and marketsdrugs licensed for use as medications. Pharmaceutical companies candeal in generic and/or brand medications. They are subject to a varietyof laws and regulations regarding the patenting, testing and marketingof drugs. The main aim of a particular
Pharmaceutical Industry
is todevelop research and distribute drugs in order to provide health carefor the people in the society. The Pharmaceutical Industry like otherindustries is subjected to follow certain rules and regulations. The
Pharmaceutical Industry
needs to follow rules about patent,marketing as well as testing of drugs that are scheduled to come tothe market as medicines. Since the inauguration of the PharmaceuticalIndustry in the 19th century, it has covered a long way and now it hasbecome one of the most influential and successful industry in the worldwith both controversy and praise on its part.
PharmaceuticalIndustry
is very much dependent upon the developments anddiscoveries that are made to search new types of drugs and also tosearch for new kind of medicines. One can also see differences withinthe industry regarding the same drug or report and differentcompanies within the Pharmaceutical Industry look to follow differentpaths for the same thing.Drug Discovery and Drug Innovation are two very aspects in thePharmaceutical Industry:
Drug Discovery:
Drug Discovery is a process through which potentialdrugs are designed or discovered. It has been observed in the pastthat most of the drugs were invented by means of isolating the activecomponent from remedies which are traditional in nature or throughanother kind of discovery known as serendipitous discovery.
Drug Development:
This process is taken forward after the discoveryis done and a thing is identified as a potential drug. The developmenttakes place immediately after that as the component is turned into amedicine. So this is also considered as a very important process andhas great importance in the Pharmaceutical Industry.For the first time ever, in 2006, global spending on prescription drugstopped $643 billion, even as growth slowed somewhat in Europe andNorth America. The United States accounts for almost half of theglobal pharmaceutical market, with $289 billion in annual salesfollowed by the EU and Japan. Emerging markets such as China,
 
Russia, South Korea and Mexico outpaced that market, growing a huge81 percent.US profit growth was maintained even whilst other top industries sawslowed or no growth. Despite this, the pharmaceutical industry is —and has been for years — the most profitable of all businesses in theU.S. In the annual Fortune 500 survey, the pharmaceutical industrytopped the list of the most profitable industries, with a return of 17%on revenue.
RevenueRank 2008Company CountryTotal Revenues(USD millions)Healthcare R&D2008(USD millions)Net inco2008(USD milli
1Pfizer
[3]
 (withWyeth
[4]
 )U.S.71,13011,31814,1112Johnson & JohnsonU.S.61,095NA10,5763GlaxoSmithKlineUnitedKingdom45,4476,37310,4324Bayer 
[5]
Germany44,6643,7706,4485Hoffmann–La RocheSwitzerland40,315NA8,1356Sanofi-AventisFrance39,997NA7,204 7NovartisSwitzerland39,800NA11,946 8AstraZenecaUK/Sweden29,559NA5,9599Abbott Laboratories
[6]
 U.S.29,5272,6884,88010Merck & Co.U.S.23,8504,6787,80811Bristol-Myers SquibbU.S.19,977NA2,16512Eli Lilly and CompanyU.S.18,634NA92,95313AmgenU.S.14,2683,3662,95014Boehringer IngelheimGermany13,2841,9772,16315Baxter InternationalU.S.10,3786141,397
The
Indian Pharmaceutical Industry
today is the front runner of India’s science-based industries with wide ranging capabilities in thecomplex field of drug manufacture and technology. A highly organizedsector, the Indian Pharmaceutical Industry is estimated to be worth $4.5 billion, growing at about 8 to 9 percent annually. It ranks veryhigh in the third world, in terms of technology, quality and range of medicines manufactured. From simple headache pills to sophisticatedantibiotics and complex cardiac compounds, almost every type of medicine is now made indigenously.
of 00

Leave a Comment

You must be to leave a comment.
Submit
Characters: ...
You must be to leave a comment.
Submit
Characters: ...